title: Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older--United States, 2015.
abstract: In October 2014, the Advisory Committee on Immunization Practices (ACIP) approved the Recommended Immunization Schedule for Adults Aged 19 Years or Older, United States, 2015. This schedule provides a summary of ACIP recommendations for the use of vaccines routinely recommended for adults aged 19 years or older in two figures, footnotes for each vaccine, and a table that describes primary contraindications and precautions for commonly used vaccines for adults. Changes in the 2015 adult immunization schedule from the 2014 schedule included the August 2014 recommendation for routine administration of the 13-valent pneumococcal conjugate vaccine (PCV13) in series with the 23-valent pneumococcal polysaccharide vaccine (PPSV23) for all adults aged 65 years or older, the August 2014 revision on contraindications and precautions for the live attenuated influenza vaccine (LAIV), and the October 2014 approval by the Food and Drug Administration to expand the approved age for use of recombinant influenza vaccine (RIV). These revisions were also reviewed and approved by the American College of Physicians, American Academy of Family Physicians, American College of Obstetricians and Gynecologists, and American College of Nurse-Midwives.
authors: David K
authors: DK
authors: Kim
authors: Carolyn B
authors: CB
authors: Bridges
authors: Kathleen H
authors: KH
authors: Harriman
mesh_terms: D000328:Adult; D026683:Advisory Committees; D000368:Aged; D002487:Centers for Disease Control and Prevention, U.S.; D006801:Humans; D007115:Immunization Schedule; D007252:Influenza Vaccines / Q000008:administration & dosage*; D008875:Middle Aged; D022242:Pneumococcal Vaccines / Q000008:administration & dosage*; D017410:Practice Guidelines as Topic; D014481:United States; D014613:Vaccines, Attenuated / Q000008:administration & dosage; D018074:Vaccines, Conjugate / Q000008:administration & dosage
chemical_list: C538862:13-valent pneumococcal vaccine; D007252:Influenza Vaccines; D022242:Pneumococcal Vaccines; D014613:Vaccines, Attenuated; D018074:Vaccines, Conjugate
references: MMWR Morb Mortal Wkly Rep. 2014 Aug 15;63(32):691-7
references: 25121712
references: MMWR Morb Mortal Wkly Rep. 2014 Sep 19;63(37):822-5
references: 25233284
references: Ann Intern Med. 2016 Feb 2;164(3):184-94
references: 26829913